Supervised spectral analysis distinguishes colorectal precancerous lesions in a 100-person serum study
Source check: Source checked. Not independent scientific confirmation.
Finding: A serum spectroscopy study analyzed 30 healthy controls,30 people with colorectal precancerous lesions and 40 with colorectal cancer. Supervised class-discrimination optimization after principal-component analysis distinguished these groups in five-fold cross-validation; the reported precancer-versus-other-groups AUC was 0.96. These are internal classification results from 100 participants, without an independent screening cohort or demonstrated clinical benefit. Spectral differences do not establish a molecular disease mechanism.
Technology: Optimal Class Discrimination and Compactness Optimization; support vector machine; k-nearest neighbors
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- After PCA preprocessing, supervised Optimal Class Discrimination and Compactness Optimization learned separation of diagnostic classes from labeled spectra. SVM and nearest-neighbor classifiers provided comparison models; PCA alone is not the enabling AI contribution.
- Test and result
- Five-fold cross-validation of spectra from 100 participants across three diagnostic groups; source reports precancer-versus-other-groups AUC 0.96. Multiple measurements per sample were averaged before analysis.
- Limitation / still unknown
- No external patient cohort, prospective screening validation or treatment-benefit study. Methods report averaging five spatial spectra per sample and five-fold cross-validation, but do not explicitly establish patient-grouped fold assignment or fold-local PCA and component selection; reported internal spectral classification is not established patient-level screening performance. Biochemical interpretations remain associations.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.1002/btm2.70019 · https://pmc.ncbi.nlm.nih.gov/articles/PMC12478330/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Exact primary article-front DOI/title/PMCID and date; full relevant model Methods, Results and limitations; fresh PubMed publication types and correction/retraction relationship metadata..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.